Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer
Clinical trial NCT03498326 · RECRUITING
Trial details
- NCT number
- NCT03498326
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2023-03-31
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.